EQUITY ALERT: Rosen Law Firm Encourages Aurinia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
CLASS ACTION UPDATE for AI, SDIG and AUPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Aurinia Pharmaceuticals Inc. Investors of Class Action and Encourages Investors to Contact the Firm Pharmaceutical Investing
LAWSUITS FILED AGAINST MP, CRNC and ABBV - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS Pharmaceutical Investing
ROSEN, A TOP RANKED FIRM, Encourages AbbVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, IBM and MYPS Pharmaceutical Investing
SHAREHOLDER ALERT: Holzer & Holzer Announces a Class Action Was Filed on Behalf of Aurinia Pharmaceuticals Investors and Encourages Investors With Significant Losses To Contact the Firm Pharmaceutical Investing
Securities Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AbbVie and Twitter and Encourages Investors to Contact the Firm Pharmaceutical Investing
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline - AUPH Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against AbbVie, Inc. with Lead Plaintiff Deadline Approaching Pharmaceutical Investing
